retatrutide side effects trial results Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide cardiac side effects 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀

GLP-1RA has been placed prominently in the international recommendations for the treatment of T2D as the first injectable agent before insulin due to the advantageous outcomes in cardiovascular safety studies that demonstrated a reduction of the combined cardiovascular endpoint three-component major adverse cardiovascular event (MACE-3

Patients should be aware that persistent vomiting or diarrhoea can lead to dehydration , and adequate fluid intake is important

These results make the Retatrutide vs Tirzepatide weight loss comparison one of the most compelling in recent metabolic pharmacology literature, though Phase 3 confirmation remains pending

Step 6: Inspect the solution

They highlight the significance of tracking important metrics like dosage, side effects, protein intake, body composition, and heart rate variability using a dashboard tool, Heads Up, for improved results

Consistency is key, especially when appetite is low